Is dose/time fractionation important in treating rectal cancer?

Area of Science:

• Radiation Oncology
• Medical Physics
• Clinical Oncology

Background:

• Rectal cancer treatment often involves radiation therapy.
• Optimizing radiation dose per fraction is crucial for improving treatment efficacy.
• Conventional fractionation may not achieve maximal tumor response.

Purpose of the Study:

• To evaluate the impact of increased dose per fraction on radiation response in rectal cancer.
• To compare the efficacy of 250 cGy/fraction versus conventional 180-200 cGy/fraction.
• To assess tumor regression rates in different clinical scenarios.

Main Methods:

• A comparative study involving two patient groups (29 each) matched for disease characteristics.
• Group A received conventional fractionation (180-200 cGy/fraction, 5 days/week).
• Group B received hyperfractionation (250 cGy/fraction, 4 days/week) with a 10% total dose reduction for biological equivalence.

Main Results:

• Significantly better tumor regression was observed in the 250 cGy/fraction group (Group B).
• Overall response (>50% regression) was 62% in Group B versus 35% in Group A.
• In preoperative cases, 90% of Group B patients showed >50% regression, with 2 achieving no evidence of disease.

Conclusions:

• Increasing the dose per fraction to 250 cGy enhances tumor regression in rectal cancer.
• Hyperfractionation with higher doses per fraction is a promising strategy for rectal cancer radiation therapy.
• This approach may improve outcomes, particularly in neoadjuvant and advanced rectal cancer settings.